Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul:108:154256.
doi: 10.1016/j.metabol.2020.154256. Epub 2020 Apr 29.

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Abdulzahra Hussain  1 , Peter Vasas  2 , Shamsi El-Hasani  3
Affiliations
Comment

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Abdulzahra Hussain et al. Metabolism. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Authors confirm no conflict of interest and no funding for this paper.

Comment on

References

    1. Zheng K.I., Gao F., Wang X.-B. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. Metabolism. 2020 doi: 10.1016/j.metabol.2020.154244. - DOI - PMC - PubMed
    1. Sheka A.C., Adeyi O., Thompson J., Hameed B., Crawford P.A., Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA. 2020 Mar 24;323(12):1175–1183. doi: 10.1001/jama.2020.2298. [Review] - DOI - PubMed
    1. Ooi G.J., Burton P.R., Bayliss J., Raajendiran A., Earnest A., Laurie C. Effect of body mass index, metabolic health and adipose tissue inflammation on the severity of non-alcoholic fatty liver disease in bariatric surgical patients: a prospective study. Obes Surg. 2019 Jan;29(1):99–108. doi: 10.1007/s11695-018-3479-2. - DOI - PubMed
    1. Albhaisi S., Sanyal A.J. Applying non-invasive fibrosis measurements in NAFLD/NASH: progress to date. Pharmaceut Med. 2019 Dec;33(6):451–463. doi: 10.1007/s40290-019-00305-z. - DOI - PubMed
    1. Nikai H., Ishida K., Umemura A., Baba S., Nitta H., Sugai T. Effects of laparoscopic sleeve Gastrectomy on non-alcoholic steatohepatitis and liver fibrosis in Japanese patients with severe obesity. Obes Surg. 2020 Mar 2 doi: 10.1007/s11695-020-04515-2. [Epub ahead of print] - DOI - PubMed